Gossamer Bio Inc (GOSS)
0.6498
-0.06
(-8.26%)
USD |
NASDAQ |
Apr 25, 11:45
Gossamer Bio Shareholders Equity (Quarterly): 62.77M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 62.77M |
| September 30, 2023 | 104.62M |
| June 30, 2023 | -62.80M |
| March 31, 2023 | -28.46M |
| December 31, 2022 | 12.08M |
| September 30, 2022 | 56.35M |
| June 30, 2022 | -16.46M |
| March 31, 2022 | 30.16M |
| December 31, 2021 | 121.46M |
| September 30, 2021 | 169.81M |
| June 30, 2021 | 220.69M |
| March 31, 2021 | 272.08M |
| Date | Value |
|---|---|
| December 31, 2020 | 320.68M |
| September 30, 2020 | 372.10M |
| June 30, 2020 | 420.32M |
| March 31, 2020 | 306.46M |
| December 31, 2019 | 352.48M |
| September 30, 2019 | 398.87M |
| June 30, 2019 | 441.44M |
| March 31, 2019 | 480.26M |
| December 31, 2018 | -120.07M |
| September 30, 2018 | 246.59M |
| December 31, 2017 | -6.862M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-62.80M
Minimum
Jun 2023
441.44M
Maximum
Jun 2019
187.09M
Average
169.81M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 160.17M |
| TG Therapeutics Inc | 160.50M |
| Replimune Group Inc | 421.54M |
| 89bio Inc | 536.31M |
| Moderna Inc | 13.85B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 311.92M |
| Total Liabilities (Quarterly) | 249.15M |